Full-Time

Regulatory Affairs Manager

Posted on 4/23/2025

Deadline 5/14/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Sant Cugat del Vallès, Barcelona, Spain

Category
Risk & Compliance
Legal & Compliance
Required Skills
Risk Management
Requirements
  • Relevant University Degree in Science or related discipline.
  • Regulatory experience within the biopharmaceutical industry, or at a health authority, or other relevant experience.
  • General knowledge of drug development.
  • Strong project management skills.
  • Leadership skills, including experience leading multi-disciplinary project teams.
Responsibilities
  • Understand the regulatory framework, including regional trends, for various types of applications and procedures for small and large molecules across all regions.
  • Provide regulatory input on procedural and documentation requirements as defined by Health Authorities for assigned deliverable(s).
  • Lead and/or contribute to the planning, preparation (including authoring where relevant) and delivery of simple and increasingly more complex submissions throughout the product’s life cycle.
  • Develop, execute and maintain submission delivery plans, submission content plans, and proactively provide status updates to designated stakeholders.
  • Coordinate the input, maintenance and revision in the Planit project plans for assigned projects and highlight unforeseen changes in resource demand in a timely manner to Lead RPM and line manager.
  • Identify regulatory risks and propose mitigations to Lead RPM and cross-functional teams.
  • Support operational and compliance activities for assigned deliverables, including generating work requests and submission content plans, submission tracking, TMF, and document management.
  • Provide coaching, mentoring and knowledge sharing within the RAM skill group.
  • Contribute to process improvement.
Desired Qualifications
  • Regulatory experience.
  • Managed regulatory deliverables at the project level.
  • Thorough knowledge of the drug development process.
  • Knowledge of AZ Business and processes.

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before they reach the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by providing effective treatments for serious diseases while collaborating with the scientific community to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EsoBiotec enhances AstraZeneca's cell therapy capabilities and market position.
  • New manufacturing facilities in Rockville and Wuxi expand AstraZeneca's production capacity globally.
  • Positive trial results for Enhertu strengthen AstraZeneca's competitive edge in oncology.

What critics are saying

  • Increased competition in oncology may impact AstraZeneca's market share.
  • Potential regulatory delays could affect the launch of new therapies.
  • High operational costs of new facilities may strain AstraZeneca's financial resources.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative drugs and therapies.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
May 20th, 2025
Acquisition Of Esobiotec Completed

20 May 2025 Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition (https://www.astrazeneca.com/media-centre/press-releases/2025/astrazeneca-to-acquire-esobiotec.html) of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers and could offer many more patients access to transformative cell therapy treatments delivered in just minutes rather than the current

BioBuzz
May 12th, 2025
AstraZeneca Opens New Cell Therapy Manufacturing Facility in Rockville, Signaling Major Boost to Maryland's Biotech Economy

In collaboration with general contractor CRB, a life sciences design and construction firm, AstraZeneca embedded operational redundancy and agility into every layer of the facility's architecture.

The Pharma Letter
May 12th, 2025
AstraZeneca breaks ground on $475 million drug plant in Wuxi

AstraZeneca breaks ground on $475 million drug plant in Wuxi.

MocoShow
May 9th, 2025
AstraZeneca Opens $300 Million CAR-T Manufacturing Facility in Rockville, Creating Over 150 Jobs

AstraZeneca opens $300 million CAR-T manufacturing facility in Rockville, creating over 150 jobs.

Cision
May 9th, 2025
Imfinzi Improved Dfs In Early Bladder Cancer

Imfinzi improved DFS in early bladder cancer

INACTIVE